RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy
2014 ◽
Vol 50
(11)
◽
pp. 1973-1981
◽
2009 ◽
pp. 285-293